Future horizons in cardiovascular molecular therapeutics (Q40874945)

24 September 2017

1 reference

title

Future horizons in cardiovascular molecular therapeutics (English)

1 reference

24 September 2017

V J Dzau

1

1 reference

24 September 2017

G H Gibbons

series ordinal

2

1 reference

24 September 2017

M Mann

series ordinal

3

1 reference

24 September 2017

R Braun-Dullaeus

series ordinal

4

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 November 1997

1 reference

American Journal of Cardiology

24 September 2017

1 reference

24 September 2017

80

1 reference

24 September 2017

9A

1 reference

24 September 2017

33I-39I

1 reference

The pathogenesis of atherosclerosis: a perspective for the 1990s

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Advanced glycation endproducts interacting with their endothelial receptor induce expression of vascular cell adhesion molecule-1 (VCAM-1) in cultured human endothelial cells and in mice. A potential mechanism for the accelerated vasculopathy of dia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Role of oxidized LDL and antioxidants in atherosclerosis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Dietary correction of hypercholesterolemia in the rabbit normalizes endothelial superoxide anion production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Genetic evidence for a common pathway mediating oxidative stress, inflammatory gene induction, and aortic fatty streak formation in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Vascular cell adhesion molecule-1 (VCAM-1) gene transcription and expression are regulated through an antioxidant-sensitive mechanism in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Induction and stabilization of I kappa B alpha by nitric oxide mediates inhibition of NF-kappa B.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Chronic inhibition of nitric oxide production accelerates neointima formation and impairs endothelial function in hypercholesterolemic rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Is NO an endogenous antiatherogenic molecule?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Blockade of Platelet GPIIb/IIIa Receptors as an Antithrombotic Strategy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Egr-1-induced endothelial gene expression: a common theme in vascular injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Regulation of vascular smooth muscle cell migration and proliferation in vitro and in injured rat arteries by a synthetic matrix metalloproteinase inhibitor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Randomised trial of coronary intervention with antibody against platelet IIb/IIIa iritegrin for reduction of clinical restenosis: results at six months

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

The emerging concept of vascular remodeling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Cell biology of atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Convergence of angiotensin II and platelet-derived growth factor receptor signaling cascades in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Electroporation of pp60c−srcAntibodies Inhibits the Angiotensin II Activation of Phospholipase C-γ1 in Rat Aortic Smooth Muscle Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Direct stimulation of Jak/STAT pathway by the angiotensin II AT1 receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Angiotensin II stimulates calcium-dependent activation of c-Jun N-terminal kinase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Role of transactivation of the EGF receptor in signalling by G-protein-coupled receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Cell cycle checkpoints: preventing an identity crisis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Adenovirus-mediated over-expression of the cyclin/cyclin-dependent kinase inhibitor, p21 inhibits vascular smooth muscle cell proliferation and neointima formation in the rat carotid artery model of balloon angioplasty

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Cytostatic gene therapy for vascular proliferative disorders with a constitutively active form of the retinoblastoma gene product

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Genetic engineering of vein grafts resistant to atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

bcl-2 gene prevents apoptosis of basic fibroblast growth factor-deprived murine aortic endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Requirement for phosphatidylinositol-3 kinase in the prevention of apoptosis by nerve growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Flow-mediated endothelial mechanotransduction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Meeting highlights: nitric oxide donors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Gene therapy inhibiting neointimal vascular lesion: in vivo transfer of endothelial cell nitric oxide synthase gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle cell proliferation and migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Molecular therapies for vascular diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

Gene therapy--promise, pitfalls, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900790-X

10.1016/S0002-9149(97)00790-X

7 January 2021

Identifiers

DOI

1 reference

24 September 2017

1 reference